LILivaNova LIVN · NASDAQ
$78.14 +0.72% (+$0.56)
- Market cap
- $4.29B
- Enterprise value
- $4.13B
- P/E
- 22.8x
- Forward P/E
- 18.0x
- PEG
- -
- P/S
- 2.9x
- P/FCF
- 28.9x
- EV/EBITDA
- 22.8x
- ROIC
- 18.0%
- Gross margin
- 68.2%
- Net margin
- 12.8%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -0.9x
- Beta
- 0.88
- Free float
- 99.8%
About the company
LivaNova PLC (LivaNova) is a global company specializing in the development and manufacturing of advanced medical technologies and therapeutic solutions for the treatment of cardiovascular and neurological diseases. With an extensive portfolio of products and services, LivaNova is a significant player in the healthcare industry. The company is known for its innovative technologies in the field of cardiac surgery and neurostimulation. LivaNova PLC shares could be suitable for investors seeking investment opportunities in the healthcare technology sector and the treatment of cardiac and neurological conditions.
Sector
Healthcare
Industry
Medical - Devices
CEO
Vladimir A. Makatsaria
Employees
3,300
Headquarters
Gloucester
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number